| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $-0.36154 (Miss by $-0.28154) |
| EPS GAAP Actual | $-0.36154 (Miss by $-0.28154) |
| Revenue Actual | $0.154818B |
| Revenue Surprise | Beat by $154.818M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1.44 | 19.51 | 1.40929 | 1.46506 | 1 |
| Dec 2026 | 2.09254 | 13.43 | 2.05802 | 2.14212 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.18 | -0.18 | 0.154818B | -4.14% | 154.82M |
| FQ2 2025 (Jun 2025) | 0.18 | 0.18 | 0.16362B | -2.27% | 163.62M |
| FQ1 2025 (Mar 2025) | 0.09 | 0.09 | 0.160843B | -8.21% | 160.84M |
| FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 0.164204B | -40.49% | 164.2M |
| FQ3 2024 (Sep 2024) | 0.18 | 0.18 | 0.161233B | -59.85% | 161.23M |
| FQ2 2024 (Jun 2024) | 0.0216 | 0.0216 | 0.167334B | -71.32% | 167.33M |
| FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 0.174047B | -59.76% | 174.05M |
| FQ4 2023 (Dec 2023) | -0.33 | -0.33 | 0.230691B | -21.25% | 230.69M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.38097 | -- | 0.37478 | 0.38484 | 1 |
| FQ3 2027 (Sep 2027) | 0.14151 | -- | 0.13921 | 0.14295 | 1 |
| FQ2 2027 (Jun 2027) | 0.34659 | -- | 0.34096 | 0.35011 | 1 |
| FQ1 2027 (Mar 2027) | 0.31254 | -- | 0.30746 | 0.31572 | 1 |
| FQ4 2026 (Oct 2026) | 0.5576 | -- | 0.54393 | 0.57787 | 1 |
| FQ3 2026 (Jul 2026) | 0.50609 | 135.57 | 0.49368 | 0.52449 | 1 |
| FQ2 2026 (Jun 2026) | 0.2325 | 22.58 | 0.22872 | 0.23486 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.18B | -- | 0.18B | 0.18B | 1 |
| FQ3 2027 (Sep 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ2 2027 (Jun 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ1 2027 (Mar 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ4 2026 (Oct 2026) | 0.19B | -- | 0.18B | 0.19B | 2 |
| FQ3 2026 (Jul 2026) | 0.18B | 15.72 | 0.18B | 0.19B | 2 |
| FQ2 2026 (Jun 2026) | 0.17B | 1.89 | 0.16B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.18 | -0.18 | 100% | |
| FQ2 2025 (Jun 2025) | 0.18 | 0.18 | 100% | |
| FQ1 2025 (Mar 2025) | 0.09 | 0.09 | 100% | |
| FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 100% | |
| FQ3 2024 (Sep 2024) | 0.18 | 0.18 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0216 | 0.0216 | 100% | |
| FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 100% | |
| FQ4 2023 (Dec 2023) | -0.33 | -0.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.15B | $154.82M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.16B | $163.62M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.16B | $160.84M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.16B | $164.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.16B | $161.23M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.17B | $167.33M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.17B | $174.05M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.23B | $230.69M | 100% |